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Use of an electronic educational module to educate
advanced practice nurses on preventive care protocol
for immunocompromised patients
Simi Jesto Joseph1, Audrey Klopp2

1) DNP, APN, NP-C, 6521 Lyons St, Morton Grove, IL 60053,
2) PhD, RN, NHA, Loyola University, Chicago, IL, 2160 S 1st Ave, Maywood, IL 60153

Abstract
Introduction: Immunocompromised patients are at increased risk of infections and certain cancers due to the
immunosuppressed body as well as the immunosuppressive agents. Despite American national organizations’
specific guidelines for immunocompromised patients, reported vaccination rates and provider compliance on
preventive services is low. The aim of this study was to assess knowledge, attitude and clinical practice among
Advanced Practice Nurses (APN) in preventive care for immunocompromised patients and educating APNs to
improve their knowledge and practice skills using an evidence-based preventive care protocol. Methods: APN
members of Illinois Society of Advanced Practice Nurses (ISAPN) organization were surveyed by a needs assessment
questionnaire and descriptive analysis was done. Based on the results, an evidence-based Preventive Care Protocol
was created and implemented through a web-based Continuing Education (CE) module. A post-test was used
to evaluate the project objectives. Results: Of the 811 surveys that were sent to ISAPN members, 164 members
responded, yielding an overall response rate of 17%. The barriers identified were lack of knowledge and confidence
among practicing APNs. Forty-four out of forty-seven APN’s took the CE module with a response rate of 94%.
The post-test showed an improvement in confidence level (98%) and knowledge of APNs (p < .005) in preventive
care for immunocompromised patients. Conclusion: The web-based CE module implementing the Preventive
Care Protocol was an effective method and improved APN’s knowledge, current practice and confidence level in
preventive care for immunocompromised patients.
Keywords: Inflammatory bowel disease, immunocompromised, outpatient, infection prevention, opportunistic
infections, cancer, vaccinations, interventions

INTRODUCTION
In chronic immune mediated diseases, chronic
inflammatory process compromises the patient’s
overall quality of life, despite all the advanced
therapeutic options available. Immunosuppressive
therapy is an effective therapy for the immune
mediated disease conditions to keep patients in
disease remission. Common medical treatments now
available for immune mediated diseases include
corticosteroids, immune modulators and biologic
drugs. The inflammatory cascade that causes
chronic inflammation is due to the pivotal role of
pro-inflammatory cytokine TNF-alpha. Biologics,
otherwise known as Tumour Necrosis Factor (TNF)
inhibitors, have been shown to induce apoptosis of
the immune cells and reduce the pro-inflammatory

cytokines (Nielsen and Ainsworth, 2013). While the
efficacy is proven for immunosuppressive therapy,
the adverse effects are a concern for these patients.
Immunocompromised patients are at increased risk
of lymphomas, serious infections and tuberculosis
(Singh et al., 2013). Many healthcare providers
are aware that because of the increased incidence
of infections, ACIP (Advisory Committee on
Immunization Practices) and many American national
organizations have published clear guidelines and
recommendations for vaccinating adults, as well as
those who are immunocompromised (CDC, 2011;
Lichtenstein, Abreu, Cohen, & Tremaine, 2006;
AGA, 2006). However, healthcare providers are
non-compliant in recommending vaccinations and
appropriate cancer screenings to these group of
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patients (Gupta, Macrae and Gibson, 2011; Yeung,
Goodman and Fedorak, 2012). The major goal of
management of chronic diseases is to improve and
maintain patient’s general wellbeing or quality of life.
The important questions are: are these goals being
achieved through the national guidelines? Although
treatment guidelines for the providers are available,
how many step forward to decrease infections and
improve preventive services to immunocompromised
patients? Do providers feel that infection prevention
is important in immunocompromised patients?

Providers and Immunocompromised Patients
The Centre for Disease Control and Prevention
(CDC) recommends adult immunizations to prevent
most of the opportunistic infections. However, CDC
(2012) reported in their vaccination reports that
most adults are not vaccinated as recommended
(NFID, 2012). To explore the low rate of vaccinations
and reasons, multiple studies were reviewed. It
was discovered that most physicians never took
an immunization history and 39% agreed that
they were either concerned about the side-effects
of vaccines or did not know which vaccines to
advice during immunocompromised state (Gupta
et al., 2011; Yeung et al., 2012). It is evident that
gastroenterologists and primary care physicians
are failing to routinely monitor their patients for
vaccination and recommending vaccinations to
their immunocompromised patients (Gupta et al.,
2009; Wasan, et al. 2010). This is not a surprise in
gastroenterology practice due to the high rate of
hospitalizations with infections among Inflammatory
Bowel Disease (IBD) patients. A 30 year Danish
Cohort study (1982-2010) found a 50% increased
mortality among patients with Crohn’s disease due
to infections over a period of three decades (Jess,
Frisch and Simonsen, 2013). While this is a concern in
gastroenterology practice, other specialties that use
immunosuppressive therapy in their practice were
also found to have similar issues. McCarthy et al.,
(2012) surveyed rheumatologists, who use immune
modulators and found that a significant percentage
(34%) of rheumatologists did not perform screening
prior to initiating anti-TNF therapy and 57%
considered the patients’ primary care physicians to
be responsible for vaccination.
2

Cancers and Immunosuppressed Patients
There is an increased incidence of cervical cancer
and colon cancer among patients with IBD and
immunosuppression. Women with IBD on immune
modulators are at increased risk of cervical dysplasia
and Human Papilloma Virus (HPV) infection has
shown high association with cervical cancer (Kane et
al., 2008). A study among 134 women with a diagnosis
of IBD showed abnormal cervical histology (p=0. 04)
and all were given immune modulators. However,
fewer women with IBD are undergoing cervical
testing compared to women without IBD (Gutierrez,
2009). This indicates that most practitioners’ screening
methodologies significantly vary due to their lack
of awareness, attitude and surveillance interval
has shown to be inconsistent worldwide (AGA,
2010). The American College of Gastroenterology
recommends colonoscopy surveillance to be started
after 8 years from initial IBD diagnosis. The risk of
colon cancer increases with extensive disease. The
surveillance for Crohn’s disease and Ulcerative
colitis are at similar interval and a small bowel
evaluation is recommended along with colonoscopy
for Crohn’s disease patients (AGA, 2010; ASGE,
2006; Kornbluth and Sachar, 2010). Another type of
cancer incidence seen among immunocompromised
patients was cutaneous malignancies (Kubica and
Brewer, 2012). This includes patients who have had
solid organ transplant, Human Immunodeficiency
Virus (HIV) positive patients, bone marrow
transplant patients, or anyone who is taking
chronic immunosuppressive medications for their
underlying pathology. Controversy exists as to
whether cutaneous tumors develop due to certain
immunosuppressive medications rather than solely
due to immunosuppressed body. According to
Kubica and Brewer (2012), medications associated
with an increased risk for cutaneous cancers are
azathioprine and prednisolone.

Barriers to Immunization
It is time to ponder why preventive care for
immunocompromised is underutilized and what
are the barriers in recommending those services to
this group of patients. The reasons identified for
underutilization of vaccinations include inadequate
knowledge among healthcare providers in selecting
vaccinations, timing of vaccinations, lack of awareness
among patients regarding adult immunizations
while on IBD treatment, fear of vaccinations, lack of
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providers available to uninsured populations and
lack of discussion on infection prevention during
a visit (Yeung et al., 2012). Among the reasons,
cited by patients include unaware of the need for
immunization, disliked needles and afraid of adverse
effects. Another important and interesting finding
is Nurse Practitioners (NP), Physician Assistants
(PA) and Registered Nurses (RN) were, more likely,
informing patients regarding the consequences of
missing vaccination than the patient’s MD providers
(Lu et al., 2009; Johnson, Nichol and Lipczynski,
2008).

Need for Practice Change
These issues indicate that co-coordinating preventive
care for patients, who are immunocompromised, is a
dilemma in clinical practice and that improvement
is imperative. To improve vaccination rates and
cancer screening strategies an evidence-based
standardized protocol, based on current guidelines,
is an effective way to improve vaccination adherence
for the persons who are immunocompromised.
Primary and secondary prevention methods are
essential for immunocompromised patients to
reduce disability and lower health care cost. These
preventive services should be provided by every
practitioner to their immunocompromised patients.
According to the American Academy of Nurse
Practitioner database 2011-2012, there are over 171,
000 nurse practitioners practicing in the U S. Eightyeight percent of NPs are prepared to practice in
primary care and at least 68% of NPs practice in at
least one primary care setting (AANP, 2012). While
the debate between specialists and primary care
providers continue, there is a great opportunity for
increasing the number of APNs currently working
in preventive care settings to address the problem of
poor adherence to vaccinations for patients who are
immunocompromised. Thus, the overall objectives
of this evidence-based study were: 1) To identify and
overcome barriers in recommending preventive care
for immunocompromised patients, 2) To improve
APNs knowledge, skills and clinical practice in
preventive care among immunocompromised
patients, 3) To create and improve usage of evidencebased preventive care protocol and 4) To provide
confidence to APNs in practicing preventive care for
immunocompromised patients through an electronic
educational module.

MATERIALS AND METHODS
ISAPN is a professional organization in Illinois State,
United States, dedicated to promotion and advocacy
of APNs. The study sample was a convenience
sample from the existing membership list of ISAPN,
which comprises about 811 APNs [Certified Nurse
Mid-wife (33), Certified Nurse Anaesthetists (15),
Certified Nurse Practitioners (645) and Certified
Nurse Specialists (118)]. The student members
were excluded from the study. A 32 item electronic
questionnaire was developed and used as the needs
assessment tool to assess APNs’ knowledge, attitude
and clinical practice patterns in preventive care for
immunocompromised patients. Two professors in
nursing contributed to the development of the survey
tool. To improve the content validity of the survey
tool, a pilot testing was done among five APNs,
who work in different clinical settings. The feedback
provided by them were used to evaluate the validity
of the questionnaire, length of the survey, quality
and the clarity of the content, inter-rater reliability
and the feasibility of using the tool among APNs.
The study was approved by the Institutional Review
Board at Loyola University, Chicago. A cover letter
describing the purpose and confidentiality of the
responses to the questionnaire were sent to ISAPN
members via e-mail as a recruitment strategy for
the Needs Assessment Survey; participation was
voluntary. The survey was released on February
24, 2014 and closed on March 10, 2014. In addition,
a reminder e-mail was sent out after 7 days of the
release to remind APNs that the survey was open
and responses would be appreciated.
The participants recommended and encouraged
a standardized protocol and to include current
guidelines as an effective way to solve the current
issue on under-vaccination for immunocompromised
patient population. Attention turned to develop an
evidence-based preventive care protocol for immune
compromised patients and towards the education,
infection and cancer prevention. The protocol was
created from the concise recommendations on
preventive care by CDC (CDC, 2014; CDC, 2011),
American Gastroenterology Association (Allen
and Dassopoulos, 2011), American Society of
Gastroenterology Endoscopy (ASGE, 2006), American
College of Gastroenterology (Kornbluth and Sachar,
2010), American College of Rheumatology (Singh
et al., 2012), American Congress of Obstetrics and
Gynecology (ACOG, 2010) and experts from the field

Manipal Journal of Nursing and Health Sciences • January 2015 (Volume 1, Issue 1)

3

Joseph SJ, et al: Use of an electronic educational module to educate advanced.....
of IBD treatment (Melmed, 2009; Lu et al., 2009; Viget,
et al., 2008; Wasan et al., 2010; Yeung, Goodman and
Fedorack, 2012). The protocol delineates appropriate
clinical and laboratory work-up during the patients’
disease treatment course or before initiating
immunosuppressive therapy. The clinical workup focuses on the past medical history, vaccination
history, travelling history and previous infections.
The protocol includes routine blood sample analysis,
including titers of Hepatitis B Surface Antigen,
Varicella Zoster IgG, MMR titers and TB skin test.
The implementation of the evidence-based protocol
was accomplished through a Continuing Education
(CE) module based on evidence as well as input from
a Needs Assessment Survey. A one hour CE module
was created and accredited by American Association
of Nurse Practitioners (AANP) CE Department.
The web-based teaching module, released through
ISAPN, provided information on type and timing
of vaccinations, specific education to patients and
their families and cancer prevention strategies for
patients who are immunocompromised. At the end
of the module, a post-test was used to assess the
knowledge of APNs gained through the module
and questions were asked to evaluate the impact of
CE module as well as the preventive care protocol.
All participants were given one hour CE certificate
accredited by AANP after completing the module,
post-test and evaluation.

72% of APN had vaccinations in stock, 32% never
administer and 15% said they rarely administer
vaccines. If APNs were not administering vaccines
in their practice, 37% reported that they refer them
to patients’ primary care provider, 36% refer them
to local health department and 30% do not make
any referrals. One hundred sixteen APNs indicated
that CDC is the organization that they rely on for
vaccination guidelines. However, those APN’s
responses indicated that only 50% are recommending
influenza and 35% are recommending pneumococcal
vaccines (Figures 1 and 2) and 23% were incorrectly
recommending a live vaccine, varicella vaccine, to
their immunocompromised patients.

Fig. 1: Needs Assessment Survey: Result of APN’s Current
Practice on Vaccinating Adults

RESULTS
Of the 811 surveys sent, 164 APNs responded,
yielding an overall response rate of 17%. Twenty
five surveys were excluded due to incomplete
response. Majority of the participants were Certified
Nurse Practitioners (CNP), practicing in Adult and
Family specialities (56%) and 66% of respondents
had been practicing for over six years. Twentyfour percent of responding APNs reported taking
care of immunocompromised patients weekly and
16% were seeing at least one immunocompromised
patient daily. Only 54 APNs reported that they ask
patients about their immunization history during
each visit and update patients on vaccination status.
APNs were not consistent in placing importance
on documenting vaccination history. Forty-three
percent report documenting the vaccination history
‘always’ and 16% said they ‘never’ document
it. Among the survey participants, only 24 were
prescribing vaccinations routinely. Even though
4

Fig. 2: Needs Assessment Survey: Result of APN’s Current
Practice on Vaccinating Immunocompromised patients

Regarding immunization recommendation to
their immunocompromised patients, lack of
confidence was identified among APNs (20%)
through the Needs Assessment Survey. It was also
found that APNs have poor knowledge on current
recommendations on cervical cancer screening
(61%), colon cancer screening (39%) and awareness
of skin cancers among immunocompromised (41%).
Majority of the APNs demonstrated appropriate
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knowledge on infection prevention and educating
their immunocompromised patients about infection
prevention (89%). However, 35% APNs never
educated patients on self-skin exams as a
routine teaching. It is surprising that only 55%
discussed smoking status and cessation with
immunocompromised patients on a daily basis.
The results regarding knowledge on vaccination
recommendations
for
family
members
of
immunocompromised were poor. APNs were not
aware of vaccination recommendations for family
members of immunocompromised patients. Ninety
percent of APNs requested for a check list in
preventive care and indicated willingness to take an
educational module to improve their clinical practice.

Fig. 3: Post-test showing percentage of participants correctly
identifying vaccinations for immunocompromised patients

Forty-seven APN’s took the CE module and forty
four APNs completed the post-test evaluation,
yielding a response rate of 94%. Cross tabulations
and Pearson Chi-Square tests were performed for
six relevant questions on the post-test to understand
significance (Table 1). Even though the sample size
vary between the Needs Assessment Survey (164)
and the post-test (44), ninety-six percent (P<0.005)

APNs who took the post-test correctly identified the
immunocompromised patient through past medical
history, medication list and previous documentation
in comparison to 68% on Needs Assessment Survey.
APNs correctly identified the screening tests that
need to be ordered for immunocompromised patients
(98%, P<. 005), up from 2% on the Needs Assessment
Survey (pre-education).
A great improvement was seen for the question
on identifying type of vaccinations to the
immunocompromised patients. The entire post-test
participants answered it correctly in comparison to
only 13% correctly identifying on Needs Assessment
Survey (Figure 3). Eighty-seven percent (P<0.005)
correctly answered cervical cancer recommendations, colon cancer recommendation (91%, P<0.005)
and skin cancer recommendation (98%, P<0.005)
in the post-test. APNs showed confidence in
recommending preventive care after completing
the module (98%). Ninety-three percent agreed that
the web-based module achieved the objective of
improving APNs’ knowledge, attitude and practice
skills in preventive care for immunocompromised
patients.

DISCUSSION
To the best of the authors’ knowledge, this is the first
project done among APNs to assess and improve
their knowledge, attitude and clinical practice on
preventive care for immunocompromised patients.
The needs assessment targeted APNs of Illinois state,
through ISAPN and it appears to be an interesting
topic to Certified Nurse Practitioners than other
specialty of APNs. Out of 164 responses to needs
assessment, 132 were Certified Nurse Practitioners
and 12 were Certified Nurse Specialists.

Table 1: Statistical significance of six questions in comparison to the Needs Assessment Survey
Needs
Assessment

Post-test

Chi-square

P Value

1. Identified patients that are immunocompromised

68%

96%

14. 7

<0.005

2. Identified screening tests for immunocompromised patients

2. 2%

98%

164. 6

<0.005

3. Identified appropriate vaccinations for immunocompromised
patients

9. 4%

100%

130. 7

<0.005

4. Identified current cervical cancer recommendations for
immunocompromised patients

40%

87%

30. 3

<0.005

5. Identified current colon cancer recommendations for IBD

27%

91%

56. 9

<0.005

6. Identified current skin cancer recommendations for
immunocompromised patients

52%

98%

130. 7

<0.005

Questions Compared
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Most of the APNs who participated in the study
agreed that they are either in the role of prescribing
therapy, educating patients and families and/
or monitoring therapy for immunocompromised
patients in their practice settings. A majority correctly
identified immunocompromised patients through
previous documentation, past medical history and
medication list. There have been concerns in previous
studies that patients were not being asked about
their vaccination history and that vaccination history
was poorly documented. The finding from the needs
assessment is not better than those studies. Only
39% of APNs asked patients about their vaccination
history during each visit and only 42 % documented
it. Thirty-five percent of APNs review patients’
vaccination history annually. It is evident that poor
documentation is still a concern among APNs. Most
of the patients may not remember their vaccination
dates and type of vaccine received. Hence, the
appropriate history taking by practitioners may be
limited by this variable. Although most of the study
participants’ clinical practices carry vaccines, very
few APNs administer or prescribe vaccines to their
patients. Thirty-seven percent of APNs are referring
their patients to primary care providers and local
health departments (36%) for adult immunization
needs. This raises a question as to why APNs are not
initiating preventive care in their own practice. Are
they afraid of side effects? Do they lack knowledge
on providing appropriate vaccinations to their adult
patients? Or do they lack confidence in prescribing
vaccines because they are unsure about the timing
of vaccinations? However, 23% of the survey
participants admitted that they were not confident
in prescribing live or attenuated vaccinations to their
adult and immunocompromised patients. Only 20%
said that they are very confident in administering or
prescribing the vaccinations to their patients.
It was important in this project to identify the barriers
in APN practice. The Needs Assessment Survey was
the method to discover the basic knowledge of APNs
in identifying correct vaccinations for their adult
and immunocompromised patients. Eighty-three
percent respondents agreed that they are relying
on CDC for up-to-date vaccination guidelines
in order to prescribe it. However, knowledge
on type of screening tests and vaccinations to
immunocompromised patients were suboptimal.
Sixty-two percent never knew that they need to
screen patients who are on immunosuppressive
6

therapy for hepatitis B, 73% never knew about
screening for varicella antibody and MMR titers and
60% never knew that they need to screen for TB, if
patients are on biologic therapy like Remicade® or
Humira®. APNs were not aware that any of these
viruses can be fatal to their immunocompromised
patient population on immunosuppressive therapy
and that screenings should be initiated prior to
starting any of the immunosuppressive drugs. If
all providers are conscientious about carrying out
preventive measures at the appropriate time, many
hospitalizations and infections could be greatly
reduced for immunocompromised patients. Even
though some participants are proficient in identifying
correct vaccinations for their immunocompromised
patients, it is a matter of concern that still a significant
number of APNs lack knowledge on vaccination
recommendations to their immunocompromised
patients; this is especially troubling with regard
to live vaccines. It is dangerous and could be
construed as malpractice if APNs prescribe live
vaccinations to immunocompromised patients. This
was a major concern after the Needs Assessment
Survey was completed. Again, knowledge deficit
may explain the reasons APNs avoid prescribing
or recommending vaccinations to their patients
and thus, miss an opportunity to prevent infections
in their immunocompromised patients. To create
strategies to improve practice, the preventive care
protocol checklist may be a useful tool, which may
be kept in patient examination rooms to remind
APNs regarding discussion and documentation of
vaccination history, schedule and recommendations.

Limitations
There are several limitations to this study. The project
did not include all ISAPN members; of 811 members
in this organization, only 164 were interested in
participating in the needs assessment and 47 for
CE module. To achieve the goal of improving
knowledge of all APNs, other nursing organizations
need to be contacted to implement the educational
module and preventive care protocol. Another issue
noticed after completing the project was regarding
questions on the Needs Assessment Survey. There
were no questions to identify reasons for not having
confidence in recommending vaccinations. There
may be many other barriers other than knowledge
deficit. The operation of each practice and the
opinions of collaborative practitioners can be an
influencing factor in determining which protocol
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needs to be followed in any given practice. The
author believes that, to identify many other barriers
in practicing evidence-based medicine in preventive
care for immunocompromised patients, further
study is needed.

2.

CONCLUSION
A paradigm shift is needed in how APNs initiate
preventive care for immunocompromised patients,
in order to improve patients’ overall quality of life.
Improving the skills of APNs in preventive care,
through the ISAPN organization, has benefited
the organization in terms of the organization’s
ability to provide up-to-date information to its
members. Once APNs build the confidence in
providing preventive care and recommending
appropriate adult vaccinations, the overall health
of immunocompromised patients will improve. The
preventive care protocol is provided to APNs in a
check list format, which is easy to understand and
follow while treating a patient for 15 to 20 minutes in
any provider’s office. This educational module will
be disseminated to other organizations to include
other APNs nationwide. The follow up in 3 months
and 6 months will be done among APNs to better
understand the usage of the protocol, sustainability
of the confidence level and any other barriers that
developed throughout the implementation of the
preventive care protocol.
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